Photodynamic antimicrobial activity of new porphyrin derivatives against methicillin resistant Staphylococcus aureus

Taşlı H. , Akbiyik A., Topaloglu N., Alptüzün V. , Parlar S.

JOURNAL OF MICROBIOLOGY, vol.56, no.11, pp.828-837, 2018 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 56 Issue: 11
  • Publication Date: 2018
  • Doi Number: 10.1007/s12275-018-8244-7
  • Title of Journal : JOURNAL OF MICROBIOLOGY
  • Page Numbers: pp.828-837


y Methicillin resistant Staphylococcus aureus (MRSA) with multiple drug resistance patterns is frequently isolated from skin and soft tissue infections that are involved in chronic wounds. Today, difficulties in the treatment of MRSA associated infections have led to the development of alternative approaches such as antimicrobial photodynamic therapy. This study aimed to investigate photoinactivation with cationic porphyrin derivative compounds against MRSA in in-vitro conditions. In the study, MRSA clinical isolates with different antibiotic resistance profiles were used. The newly synthesized cationic porphyrin derivatives (P-M, P-E, P-PN, and P-PL) were used as photosensitizer, and 655 nm diode laser was used as light source. Photoinactivation experiments were performed by optimizing energy doses and photosensitizer concentrations. In photoinactivation experiments with different energy densities and photosensitizer concentrations, more than 99% reduction was achieved in bacterial cell viability. No decrease in bacterial survival was observed in control groups. It was determined that there was an increase in photoinactivation efficiency by increasing the energy dose. At the energy dose of 150 J/cm(2) a survival reduction of over 6.33 log(10) was observed in each photosensitizer type. While 200 M P-M concentration was required for this photoinactivation, 12.50 M was sufficient for P-E, P-PN, and P-PL. In our study, antimicrobial photodynamic therapy performed with cationic porphyrin derivatives was found to have potent antimicrobial efficacy against multidrug resistant S. aureus which is frequently isolated from wound infections.